Merck, Moderna, Intismeran Autogene, V940, mRNA Cancer Vaccine, KEYTRUDA, Pembrolizumab, Melanoma, Phase 3 Clinical Trial, Immuno-Oncology, Personalized Cancer Therapy, Neoantigen Therapy

Rahway, New Jersey, and Cambridge, Massachusetts, United States, October 22, 2026 Merck & Co. and Moderna, Inc. have announced...